NYSE American Net Change Percentage Gainers & Losers

GAINERS COMPANY SYMBOL LAST CHANGE PERCENT VOLUME ------- ------ ---- ------ ------- ------ NFT

Dow JonesMay 3 05:39

Radiopharma Stocks Higher as Sector Welcomes the Latest M&A Deal

Seeking AlphaMay 3 02:31

HC Wainwright & Co. : Actinium Pharma (ATNM.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $50.00.

HC Wainwright & Co. : Actinium Pharma (ATNM.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $50.00.

Zhitong FinanceApr 29 18:10

Actinium Says Phase 3 SIERRA Trial Results Of Iomab-B Shows Improving OS For AML Patients

RTTNewsApr 18 21:33

Actinium Highlights Ability of Iomab-B to Overcome High-Risk TP53 Mutation Resulting in Significant Improvement in Overall Survival in Patients With Active Relapsed Refractory AML at the European Bone Marrow Transplant Annual Meeting

-- Iomab-B led bone marrow transplant produced high rates of complete remission and durable complete remission regardless of TP53 mutation status in patients age 55 and above with high-risk active re

PR NewswireApr 18 20:00

Wall Street Bulls Eye a 290% Upside on Actinium Pharmaceuticals, Inc. Amidst Groundbreaking Cancer Therapy Innovations

EvertiseApr 2 01:42